We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
RELX Plc | EU:REN | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.76 | 1.98% | 39.10 | 38.02 | 39.30 | 39.26 | 38.40 | 38.40 | 828,976 | 16:40:00 |
By Adria Calatayud
RELX PLC said Thursday that net profit for the first half fell 30% as the coronavirus pandemic hit revenue, and that the full-year outlook for its events division is highly uncertain.
The FTSE 100 information and analytics group made a net profit of 548 million pounds ($697.8 million) for the half year compared with GBP779 million for the year-earlier period.
Adjusted operating profit fell 24% to GBP939 million, the company said.
RELX, the company behind medical journal the Lancet and the London Book Fair, said revenue declined to GBP3.50 billion in the first half from GBP3.89 billion the year before, dragged by its events division. The company didn't provide underlying figures due to the extent of event postponements and cancellations.
The board maintained its interim dividend unchanged at 13.6 pence a share, but said it doesn't intend to resume a share buyback program it suspended earlier this year.
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
July 23, 2020 02:38 ET (06:38 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year RELX Chart |
1 Month RELX Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions